Diarrhea • Inhibition of E. coli, including enterohemorrhagic O157:H7 • Cystitis • Inhibition of E. coli
- > Lactobacillus rhamnosus – LR04 (DSM 16605)
Lactobacillus rhamnosus – LR04 (DSM 16605)
Discover characteristics, functionalities and scientific support of Lactobacillus rhamnosus – LR04 (DSM 16605).
Thearapeutical Area(s): Gastrointestinal tract, Urogenital system
Age/Gender: Adults
Scientific reference(s)
Dezi A. et al. Probiotics and chronic diarrhea in the elderly. CIBUS, 2004; 8(2):58-64.
Del Piano M. et al. Comparison of the Kinetics of Intestinal Colonization by Associating 5 Probiotic Bacteria Assumed Either in Microencapsulated or in a Traditional, Uncoated Form. J Clin Gastroenterol 2012;46:S85-S92.
Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains (LP01, LP02, LR04, LR06, LPS01, LDD01, BR03, B632). J Clin Gastroenterol. 2012; 46 Suppl:S29-32.
Del Piano M. et al. In Vitro Sensitivity of Probiotics to Human Pancreatic Juice. J Clin Gastroenterol. Vol 42, Suppl. 3, Part 2, Sept. 2008.
+ Internal data on anti-inflammatory and anti-oxidant properties available upon request for some of these strains
